NLRP3 and chronic kidney disease: Moreover, to determine whether the type of underlying heart disease affects activation of the NLRP3 inflammasome, we further analyzed the protein levels of inflammasome pathway mediators in atrial tissue samples from NC and CKD patients who underwent coronary artery bypass graft surgery (CABG) and valve replacement surgery.